Phenotype of dendritic cells generated in the presence of non-small cell lung cancer antigens - Preliminary report

Folia Histochemica et Cytobiologica

Volumn 46, Issue 4, 2008, Pages 465-470

  Jankowska, Olga ^a   Krawczyk, Paweł ^a   Wojas Krawczyk, Kamila ^a   Sagan, Dariusz ^a   Milanowski, Janusz ^a   Roliński, Jacek ^a  

^a MEDICAL UNIVERSITY OF LUBLIN   (Poland)

Author keywords

Dendritic cells; Non small cell lung cancer; Vaccine

Indexed keywords

B7 ANTIGEN; CD83 ANTIGEN; CD86 ANTIGEN; HLA DR ANTIGEN; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; RECOMBINANT INTERLEUKIN 4; T6 ANTIGEN; TUMOR ANTIGEN; TUMOR NECROSIS FACTOR ALPHA; CELL EXTRACT; TUMOR MARKER;

AGED; ARTICLE; CANCER CELL; CELL ADHESION; CELL LYSATE; CELL MATURATION; CLINICAL ARTICLE; CONTROLLED STUDY; CULTURE MEDIUM; DENDRITIC CELL; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN TISSUE; LUNG NON SMALL CELL CANCER; MONONUCLEAR CELL; PERIPHERAL BLOOD MONONUCLEAR CELL; PHENOTYPE; PROTEIN EXPRESSION; PURIFICATION; CELL CULTURE; DRUG EFFECT; IMMUNOLOGY; IMMUNOPHENOTYPING; LUNG TUMOR; METABOLISM; PATHOLOGY;

AGED; ANTIGENS, NEOPLASM; CARCINOMA, NON-SMALL-CELL LUNG; CELL EXTRACTS; CELLS, CULTURED; DENDRITIC CELLS; HUMANS; IMMUNOPHENOTYPING; LUNG NEOPLASMS; PHENOTYPE; TUMOR MARKERS, BIOLOGICAL; TUMOR NECROSIS FACTOR-ALPHA;

EID: 60549089373     PISSN: 02398508     EISSN: None     Source Type: Journal    
DOI: 10.2478/v10042-008-0078-4     Document Type: Article

References (20)

1. Guermonprez P, Valladeau J, Zitvogel L, Thery C, Amigorena S. Antigen presentation and T cell stimulation by dendritic cells. Annu Rev Immunol. 2002;20:621-667.
2. O'Neill DW, Adams S, Bhardwaj N. Manipulating dendritic cell biology for the active immunotherapy of cancer. Blood. 2004;104(8):2235-2245.
3. Banchereau J, Palucka A K. Dendritic cells as therapeutic vaccines against cancer. Immunology. 2005;5:296-304.
4. Kuo-Ching Sheng, Pietersz GA, Mark D. Dendritic cell: Activation and maturation - applications for cancer immunotherapy. Curr Med Chem. 2005;12:1783-1800.
5. Cranmer LD, Trevor KT, Hersh EM. Clinical applications of dendritic cell vaccination in the treatment of cancer. Cancer Immunol Immunother. 2004;53:275-306.
6. Steinman R. Some interfaces of dendritic cell biology. APMIS. 2003;111(7-8):675-97.
7. Ardavin C, Amigorena S, Sousa CR. Dendritic cells: Immunobiology and cancer immunotherapy. Immunity. 2004; 20:17-23.
8. Raez LE, Fein S, Podack ER. Lung cancer immunotherapy. Clin Med Res. 3(4):221-228.
9. Sato K, Fujita S. Dendritic cells-nature and classification. Allergol Int. 2007;56:183-191.
10. Watanabe S, Kagamu H, Yoshizawa H et al. The duration of signaling through CD40 directs biological ability of dendritic cells to induce antitumor immunity. J Immunol. 2003;171: 5828-36.
11. Nouri-Shirazi M, Banchereau J, Fay J, Palucka K. Dendritic cell based tumor vaccines. Immunology Letters. 2000;74:5-10.
12. Ryncarz RE, Anasetti C. Expression of CD86 on human marrow CD34+ cells identifies immunocompetent committed precursors of macrophages and dendritic cells. Blood. 1998; 91(10):3892-3900.
13. Dilioglou S, Cruse JM, Lewis RE. Function of CD80 and CD86 on monocytes- and stem cell-derived dendritic cells. Exp Mol Pathol. 2003;75:217-227.
14. Ishikawa A, Motohashi S, Ishikawa E, Fuchida H, Higashino K, Otsuji M et. al. A Phase I study of A-Galactosylceramide (KRN7000)-pulsed dendritic cells in patients with advanced and recurrent non-small cell lung cancer. Clin Cancer Res. 2005;1(11):1910-17.
15. Chang GC, Lan HC, Juang SH, Wu YC, Lee HC, Hung MY. A pilot clinical trial of vaccination with dendritic cells pulsed with autologous tumor cells derived from malignant pleural effusion in patients with late-stage lung carcinoma. Cancer. 2005;103(4):763-771.
16. Hirschowitz EA, Foody T, Kryscio R, Dickson L, Sturgill J, Yanneli J. Autologous dendritic cell vaccines for non-small cell lung cancer. J Clinl Oncol. 2004;22(14):2808-2815.
17. Hirschowitz E, Foody T, Hidalgo G, Yannelli J. Immunization of NSCLC patients with antigen-pulsed immature autologous dendritic cells. Lung Cancer. 2007;57(3):365-372.
18. Itoh T, Ueda Y, Kawashima I, Nukaya I, Fujiwara H, Fuji N et. al. Immunotherapy of solid cancer using dendritic cells pulsed with the HLA-A24-restricted peptide of carcinoembryonic antigen. Cancer Immunol Immunother. 2002;51:99-106.
19. Babatz J, Rollig Ch, Lobel B, Folprecht G, Hoack M, Gunther H et. al. Induction of cellular immune responses against carcinoembryonic antigen in patients with metastatic tumors after vaccination with altered peptide ligand-loaded dendritic cells. Cancer Immunol Immunother. 2006;55:268-276.
20. Yoshida S, Morii K, Watanabe M, Saito T, Yamamoto T, Tanaka R. The generation of anti-tumoral cells using dendritic cells from the peripheral blood of patients with malignant brain tumors. Cancer Immunol Immunother. 2001;6(50):321-7.